Real-world effectiveness of daclatasvir plus sofosbuvir and velpatasvir/sofosbuvir in hepatitis C genotype 2 and 3-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-world effectiveness of daclatasvir plus sofosbuvir and velpatasvir/sofosbuvir in hepatitis C genotype 2 and 3

Published:2019-01 Issue:1 Volume:70 Page:15-23
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Belperio Pamela S.,Shahoumian Troy A.,Loomis Timothy P.,Mole Larry A.,Backus Lisa I.^ORCID

Publisher

Elsevier BV

Subject

Hepatology

Reference20 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study;The Polaris Observatory HCV Collaborators;Lancet Gastroenterol Hepatol,2017

2. Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes;Petruzziello;World J Gastroenterol,2016

3. Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection;Sulkowski;N Engl J Med,2014

4. All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study;Nelson;Hepatology,2015

5. Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme;Hézode;Liver Int,2017

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C virus diversity and treatment outcomes in Benin: a prospective cohort study;The Lancet Microbe;2024-07

2. Clearance of Hepatitis C Virus following Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma: Case Report;Case Reports in Gastroenterology;2024-06-27

3. ‘Unusual’ HCV genotype subtypes: origin, distribution, sensitivity to direct-acting antiviral drugs and behaviour on antiviral treatment and retreatment;Gut;2024-05-23

4. Treatment response and adverse effects of direct acting antivirals among HCV patients carrying comorbid conditions;Future Virology;2024-03-03

5. Managing HBV and HCV Infection Pre- and Post-liver Transplant;Journal of Clinical and Experimental Hepatology;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3